The project aims to find new chemical probes to reverse toxicity caused by alpha-synuclein, a protein associated with Parkinson's disease. They will use a yeast-based assay to screen for compounds that can restore growth in cells with high levels of toxic alpha-synuclein. Compounds that inhibit alpha-synuclein will appear as activators in the assay. Is the molecule effective to this assay?